Tramadol Hydrochloride
Product Images NDC 53002-4321

4 FDA label images from Rpk Pharmaceuticals, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Tramadol Hydrochloride (NDC 53002-4321). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Label Image (Lbl530024321)

Label Image (Lbl530024321)
Tramadol Hydrochloride 50 mg tablets packaging label from RPK Pharmaceuticals, Inc., NDC 53002-4321. The label specifies a bottle containing 20 tablets and includes directions for use, refill instructions, barcode, and sections for patient and clinic information.*
FDA Label Image

Chemical Structure (Tramadol 01)

Chemical Structure (Tramadol 01)
Chemical structure of Tramadol Hydrochloride, showing the molecular arrangement including a methoxy-substituted phenyl ring, cyclohexane ring, hydroxyl group, and dimethylaminoethyl side chain with a hydrochloride component.*
FDA Label Image

Figure 1 (Tramadol 02)

Figure 1 (Tramadol 02)
A line graph showing the plasma concentration of Tramadol and its metabolite M1 over time in hours. It compares multiple dose and single dose regimens, with concentration (ng/mL) on the vertical axis and time (hours) on the horizontal axis. Multiple doses produce higher concentrations than single doses for both Tramadol and M1.*
FDA Label Image

Figure 2 (Tramadol 03)

Figure 2 (Tramadol 03)
A line graph titled 'Protocol CAPSS-047 Time to Discontinuation Due to Nausea/Vomiting' showing the percent of subjects discontinuing treatment over time. The x-axis represents days in a double-blind study up to 27 days, and the y-axis shows percent discontinuing up to 50%. The line corresponds to a 10-day titration to 200 mg/day dosage.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.